CIK: 1461466 - Address: Sunesis Pharmaceuticals, Inc., 395 Oyster Point Boulevard, Ste. 400, South San Francisco, CA 94080
3 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret112273-21-9-27-8
P%wins5010050050042

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

10/30/17 19:30
10/27/17
SNSSSunesis Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMisfeldt DaytonCADP.d8002.00040031I
12/21/15 21:31
12/21/15
SNSSSunesis Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMisfeldt DaytonCADP1,4700.840001,750139I-81-66-71-25-2-155688-2-33-34-29
7/1/10 19:51
6/30/10
SNSSSunesis Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsMisfeldt DaytonCADTP.d6,5520.2750023,824642I-6715-59-47-49-13-16-11-457-817-25

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact